SSA
ALT icon

Schonfeld Strategic Advisors’s Altimmune ALT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,021
Closed -$47K – 2172
2025
Q4 		$47K Buy
+13,021
New +$56.8K ﹤0.01% 1884
2024
Q3 		– Sell
-22,738
Closed -$151K – 2012
2024
Q2 		$151K Sell
22,738
-78,688
-78% -$581K ﹤0.01% 1845
2024
Q1 		$1.03M Sell
101,426
-33,574
-25% -$341K 0.01% 1212
2023
Q4 		$1.52M Buy
+135,000
New +$564K 0.01% 893
2023
Q3 		– Sell
-68,100
Closed -$240K – 1744
2023
Q2 		$240K Sell
68,100
-206,341
-75% -$926K ﹤0.01% 1486
2023
Q1 		$1.16M Buy
+274,441
New +$3.26M 0.01% 896
2022
Q4 		– Sell
-58,102
Closed -$742K – 2558
2022
Q3 		$742K Sell
58,102
-120,898
-68% -$1.78M 0.01% 1477
2022
Q2 		$2.09M Buy
179,000
+162,500
+985% +$1M 0.02% 733
2022
Q1 		$101K Sell
16,500
-1,400
-8% -$10.3K ﹤0.01% 2224
2021
Q4 		$164K Sell
17,900
-48,700
-73% -$517K ﹤0.01% 1789
2021
Q3 		$754K Buy
+66,600
New +$810K 0.01% 1080
2021
Q2 		– Sell
-99,834
Closed -$1.41M – 1910
2021
Q1 		$1.41M Buy
+99,834
New +$1.61M 0.02% 773
2020
Q3 		– Sell
-34,900
Closed -$374K – 1333
2020
Q2 		$374K Buy
+34,900
New +$192K 0.01% 910

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Schonfeld Strategic Advisors's ALT Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Altimmune (ALT) in Q1 2026, closing a stake of 13,021 shares — an estimated $47K sold.

Schonfeld Strategic Advisors first reported a position in ALT in Q2 2020 and held it in 13 quarters. The position peaked at $2.09M in Q2 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,021 Altimmune shares in Q1 2026, an estimated $47K.
  • Schonfeld Strategic Advisors first reported a position in Altimmune in Q2 2020 and held it in 13 quarters.
  • Schonfeld Strategic Advisors's Altimmune position peaked at $2.09M in Q2 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.